MedPath
NMPA Approval

Eptazocine Hydrobromide Injection

国药准字H20253797

April 1, 2025

Drug Information

氢溴酸依他佐辛注射液

注射剂

1ml:15mg(按C₁₅H₂₁NO计)

化学药品

April 1, 2025

Company Information

Applicant Company

安徽省合肥市经开区文山路与繁华大道交口

Manufacturing Company

安徽省合肥市经开区文山路与繁华大道交口

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸依他佐辛注射液 - NMPA 批准文号 | MedPath